Trustmark National Bank Trust Department Purchases 938 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Trustmark National Bank Trust Department increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 58.5% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,541 shares of the healthcare conglomerate’s stock after buying an additional 938 shares during the period. Trustmark National Bank Trust Department’s holdings in UnitedHealth Group were worth $1,257,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BKM Wealth Management LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $2,016,000. Etesian Wealth Advisors Inc. grew its position in UnitedHealth Group by 2.2% in the fourth quarter. Etesian Wealth Advisors Inc. now owns 980 shares of the healthcare conglomerate’s stock worth $514,000 after acquiring an additional 21 shares in the last quarter. Twelve Points Wealth Management LLC raised its position in UnitedHealth Group by 10.2% during the fourth quarter. Twelve Points Wealth Management LLC now owns 1,109 shares of the healthcare conglomerate’s stock valued at $584,000 after purchasing an additional 103 shares during the period. Lantz Financial LLC lifted its stake in UnitedHealth Group by 9.4% in the fourth quarter. Lantz Financial LLC now owns 888 shares of the healthcare conglomerate’s stock worth $468,000 after purchasing an additional 76 shares during the last quarter. Finally, Everhart Financial Group Inc. boosted its holdings in UnitedHealth Group by 16.8% during the 4th quarter. Everhart Financial Group Inc. now owns 3,811 shares of the healthcare conglomerate’s stock valued at $2,006,000 after acquiring an additional 549 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $1.66 during trading hours on Tuesday, reaching $556.87. The stock had a trading volume of 1,240,105 shares, compared to its average volume of 4,326,916. The firm has a market cap of $512.54 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 1.66 and a beta of 0.60. The firm has a 50-day moving average of $505.50 and a 200-day moving average of $500.53. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $581.50.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $6.14 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. UBS Group raised their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. HSBC increased their price target on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Piper Sandler raised their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Finally, Royal Bank of Canada boosted their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $614.17.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.